TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (FY)Dec 31, 2020 | (Q9)Sep 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -59.72%18.87M | ---- | 11.22%46.84M | ---- | -9.80%42.12M | 5.94%24.98M | 44.03%46.7M | --23.58M | -46.03%32.42M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -3,255.91%-3.12M | ---- | -97.87%-93K | ---- | -104.35%-47K | -31.58%-25K | 37.84%-23K | ---19K | 2.63%-37K |
Impairment and provisions: | ---- | -229.44%-1.19M | ---- | -16.88%-360K | ---- | -516.22%-308K | 20.09%508K | 102.72%74K | --423K | -173.24%-2.72M |
-Impairment of trade receivables (reversal) | ---- | -229.44%-1.19M | ---- | -117.09%-360K | ---- | 2,747.30%2.11M | 20.09%508K | 102.72%74K | --423K | -173.24%-2.72M |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---2.42M | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | -88.85%29K | 200.00%1K | --260K | ---1K | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | -88.85%29K | 200.00%1K | --260K | ---1K | ---- |
Depreciation and amortization: | ---- | -0.66%16.97M | ---- | 21.86%17.08M | ---- | 23.52%14.02M | 3.56%9.02M | -25.21%11.35M | --8.71M | -13.75%15.17M |
-Amortization of intangible assets | ---- | -27.66%340K | ---- | 12.71%470K | ---- | 121.81%417K | 246.07%308K | --188K | --89K | ---- |
Financial expense | ---- | -33.06%3.77M | ---- | 78.09%5.63M | ---- | 73.86%3.16M | 15.40%1.68M | -53.85%1.82M | --1.46M | -23.80%3.94M |
Special items | ---- | ---- | ---- | ---- | ---- | -245.20%-1.22M | -191.53%-1.03M | -158.39%-354K | ---354K | ---137K |
Operating profit before the change of operating capital | ---- | -48.92%35.3M | ---- | 19.66%69.1M | ---- | -3.46%57.75M | 3.96%35.13M | 22.98%59.82M | --33.79M | -43.82%48.64M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | 29.71%9.99M | ---- | 144.01%7.7M | ---- | -296.90%-17.5M | -116.54%-2.64M | -73.56%8.89M | --15.97M | 240.22%33.63M |
Accounts payable increase (decrease) | ---- | 115.32%1.87M | ---- | -263.49%-12.23M | ---- | 190.68%7.48M | 494.00%4.07M | -2.47%-8.25M | ---1.03M | -209.18%-8.05M |
prepayments (increase)decrease | ---- | 916.78%4.97M | ---- | 91.45%-608K | ---- | -764.15%-7.11M | -15.57%-5.05M | 126.50%1.07M | ---4.37M | -239.63%-4.04M |
Cash from business operations | ---- | -18.50%52.13M | ---- | 57.49%63.96M | ---- | -33.99%40.61M | -28.96%31.51M | -12.32%61.53M | --44.36M | -3.70%70.17M |
Hong Kong profits tax paid | ---- | -132.05%-10.29M | ---- | 58.26%-4.43M | ---- | 48.30%-10.62M | 99.04%-164K | ---20.55M | ---17.06M | ---- |
Special items of business | -32.72%20.97M | ---- | 9.86%31.17M | ---- | --28.37M | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | -32.72%20.97M | -29.71%41.84M | 9.86%31.17M | 98.49%59.53M | --28.37M | -26.82%29.99M | 14.85%31.35M | -41.60%40.98M | --27.3M | -3.70%70.17M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 37,812.50%3.03M | ---- | 60.00%8K | ---- | -78.26%5K | -78.95%4K | -37.84%23K | --19K | -2.63%37K |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.68%49K | --42K | 85.11%87K |
Purchase of fixed assets | ---- | 94.22%-1.25M | ---- | -332.75%-21.63M | ---- | -2,616.30%-5M | -4,900.00%-4.75M | 84.84%-184K | ---95K | 47.38%-1.21M |
Purchase of intangible assets | ---- | -22.88%-188K | ---- | -21.43%-153K | ---- | 89.53%-126K | 94.87%-61K | ---1.2M | ---1.19M | ---- |
Other items in the investment business | 60.96%-825K | ---- | 89.48%-2.11M | ---- | ---20.08M | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 60.96%-825K | 107.32%1.59M | 89.48%-2.11M | -325.36%-21.77M | ---20.08M | -288.98%-5.12M | -292.73%-4.81M | -20.73%-1.32M | ---1.22M | 50.95%-1.09M |
Net cash before financing | -30.67%20.15M | 15.05%43.43M | 250.33%29.06M | 51.80%37.75M | --8.29M | -37.30%24.87M | 1.80%26.54M | -42.58%39.67M | --26.07M | -2.21%69.08M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -85.01%7M | ---- | 33.39%46.69M | ---- | -27.05%35M | -47.89%25M | 499.71%47.98M | --47.98M | --8M |
Refund | ---- | 53.86%-28M | ---- | -488.16%-60.69M | ---- | 75.22%-10.32M | 72.68%-10.32M | 40.08%-41.64M | ---37.77M | ---69.5M |
Issuing shares | ---- | --124.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | ---- | 33.06%-3.77M | ---- | -78.09%-5.63M | ---- | -73.86%-3.16M | -15.40%-1.68M | 53.85%-1.82M | ---1.46M | 23.80%-3.94M |
Dividends paid - financing | ---- | 16.67%-10M | ---- | 72.73%-12M | ---- | -109.52%-44M | -193.33%-44M | 53.33%-21M | ---15M | ---45M |
Other items of the financing business | 80.76%-6.05M | ---- | -931.64%-31.47M | ---- | ---3.05M | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | 80.76%-6.05M | 291.62%79.29M | -931.64%-31.47M | -26.14%-41.38M | ---3.05M | -29.43%-32.8M | -196.22%-38.37M | 79.05%-25.34M | ---12.95M | -582.95%-120.98M |
Effect of rate | 57.78%-19K | 165.63%85K | -136.84%-45K | 500.00%32K | ---19K | -108.60%-8K | -112.96%-7K | 269.09%93K | --54K | 79.32%-55K |
Net Cash | 684.93%14.09M | 3,483.60%122.72M | -145.94%-2.41M | 54.28%-3.63M | --5.24M | -155.39%-7.93M | -190.12%-11.82M | 127.59%14.32M | --13.12M | -198.05%-51.9M |
Begining period cash | 616.20%142.74M | -15.28%19.93M | -15.28%19.93M | -25.24%23.53M | --23.53M | 84.53%31.47M | 84.53%31.47M | -75.29%17.05M | --17.05M | 322.26%69.01M |
Cash at the end | 797.29%156.81M | 616.20%142.74M | -39.21%17.48M | -15.28%19.93M | --28.75M | -25.24%23.53M | -35.04%19.64M | 84.53%31.47M | --30.23M | -75.29%17.05M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | 616.20%142.74M | ---- | --19.93M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash and cash equivalent balance | ---- | 616.20%142.74M | ---- | --19.93M | ---- | ---- | ---- | ---- | ---- | ---- |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.